The Discounted Cash Flow (DCF) valuation of Cosmo Pharmaceuticals NV (COPN.SW) is 137.11 CHF. With the latest stock price at 61.70 CHF, the upside of Cosmo Pharmaceuticals NV based on DCF is 122.2%.
Based on the latest price of 61.70 CHF and our DCF valuation, Cosmo Pharmaceuticals NV (COPN.SW) is a buy. buying COPN.SW stocks now will result in a potential gain of 122.2%.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 7.7% | 6.0% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 99.69 - 224.05 | 137.11 |
| Upside | 61.6% - 263.1% | 122.2% |